What is Resistomap?
Resistomap operates at the critical intersection of medicine and technology, providing a vital platform for monitoring antibiotic resistance. Headquartered in Finland, a nation recognized for its strong healthcare innovation ecosystem, the company is positioned to address a pressing global health challenge. By developing advanced monitoring solutions, Resistomap aims to equip healthcare providers and public health organizations with the data necessary to make informed decisions, thereby curbing the spread of resistant bacteria and preserving the efficacy of existing antibiotics.
How much funding has Resistomap raised?
Resistomap has raised a total of $2.2M across 1 funding round:
Angel/Seed
$2.2M
Angel/Seed (2023): $2.2M with participation from Business Finland, Gaingels, and Ananda Impact Ventures
Key Investors in Resistomap
Business Finland
Business Finland is a Finnish public organization that provides innovation funding and internationalization services, promoting travel and investments in Finland. It operates globally with a strong focus on supporting Finnish companies.
Gaingels
Gaingels is a leading investment syndicate supporting the LGBTQ community and allies in venture capital. They invest in companies with LGBT founders and inclusive teams across various sectors, from seed to growth stages.
Ananda Impact Ventures
Ananda Impact Ventures partners with founders to invest in innovative technologies addressing critical challenges in decarbonization, healthcare, and environmental sustainability, aiming to drive impactful change for a sustainable future.
What's next for Resistomap?
The recent major strategic investment signals a pivotal growth phase for Resistomap. This influx of capital is expected to accelerate the company's product development, expand its market reach, and bolster its research and development capabilities. With a clear focus on scaling its operations and enhancing its technological offerings, Resistomap is poised to make a substantial impact in the fight against antibiotic resistance, further solidifying its position as a key player in the global medtech landscape.
See full Resistomap company page
